STAA STAAR Surgical Company

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Blickensdoerfer Hans-Martin	2. Issuer Name and Ticker or Trading Symbol STAAR SURGICAL CO [ STAA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Sr. VP, Comm. Ops, China
(Last)          (First)          (Middle) 25651 ATLANTIC OCEAN DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 6/15/2020
(Street) LAKE FOREST, CA 92630 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	6/15/2020		M		19215	A	$11.00	147165	D
Common Stock	6/15/2020		M		20000	A	$5.34	167165	D
Common Stock	6/15/2020		S		39215	D	$44.07 (1)	127950	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Options	$11.00	6/15/2020		M			19215	3/2/2013 (2)	3/1/2022	Common Stock	19215	$0.00	0	D
Common Stock Options	$5.34	6/15/2020		M			20000	3/4/2014 (3)	3/3/2023	Common Stock	20000	$0.00	0	D

Explanation of Responses:
(1)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.38, inclusive.
(2)	The options vested in three equal installments on March 2, 2013, March 2, 2014, and March 2, 2015.
(3)	The options vested in three equal installments on March 4, 2014, March 4, 2015, and March 4, 2016.

Remarks: This Form 4 reflects the exercise of stock options awarded to Mr. Blickensdoerfer in 2012 and 2013.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Blickensdoerfer Hans-Martin 25651 ATLANTIC OCEAN DRIVE LAKE FOREST, CA 92630			Sr. VP, Comm. Ops, China

Signatures
/s/ Samuel Gesten as attorney-in-fact for Hans Blickensdoerfer		6/17/2020
**Signature of Reporting Person		Date